Nasdaq:US$15.24 (-0.33) | HKEX:HK$23.90 (-0.10) | AIM:£2.31 (+0.04)
News & Presentations
Previous Article   |   Next Article
Presentations, Scientific Publications | 6 Apr 2013

AACR 2013: Preclinical disposition and pharmacokinetics of savolitinib, a novel selective cMet inhibitor